System and method for facilitating extracorporeal inactivation of pathogens of blood products

    公开(公告)号:US11364330B2

    公开(公告)日:2022-06-21

    申请号:US17470371

    申请日:2021-09-09

    Abstract: A system and a method facilitate the extracorporeal inactivation of pathogens of blood products. The system includes an input peristaltic pump, at least one apheresis device, at least one plasma-treating system, and an output peristaltic pump. The input peristaltic pump, the apheresis device, the plasma-treating system, and the output peristaltic pump are in fluid communication with each other. The plasma-treating system includes at least one primary ultraviolet light (UVL) device, at least one heating device, and at least one cooling device. The input peristaltic pump facilitates the flow of blood from a patient through the system. The apheresis device facilitates separating of plasma from one or more blood cells. The plasma-treating system heats the plasma, inactivates pathogens within the plasma, and then cools the plasma. The output peristaltic pump facilitates the flow of blood from the system and back to the patient.

    VENOUS DEVICE
    4.
    发明申请
    VENOUS DEVICE 审中-公开
    通风装置

    公开(公告)号:US20110295176A1

    公开(公告)日:2011-12-01

    申请号:US12452357

    申请日:2008-06-25

    Abstract: A needle can include a fluid directing portion comprising a U-shaped lateral orifice extending between the exterior and interior surfaces and a corresponding U-shaped diverter adjacent to the U-shaped lateral orifice. A diverter can be disposed within a lumen of a needle and transverse to a central axis within the lumen.

    Abstract translation: 针可以包括流体引导部分,其包括在外表面和内表面之间延伸的U形横向孔口和与U形横向孔口相邻的相应的U形分流器。 分流器可以设置在针的内腔中并且横向于管腔内的中心轴线。

    System and Method of Automatically Preparing and Analyzing Urine Samples for Identifying Cancer Cells

    公开(公告)号:US20220034919A1

    公开(公告)日:2022-02-03

    申请号:US16945278

    申请日:2020-07-31

    Abstract: A system and method of automatically preparing and analyzing urine samples for identifying cancer cells is able to complete conventional diagnostic tasks without lab technicians, cytopathologists, or other medical professionals. The method is provided with at least one source sample, at least one manipulator arm, at least one centrifuge, at least one electronic microscope, and at least one unitary controller. The method is further provided with a cytopathological index containing a visual characteristic database and identification confidence threshold rubrics supporting the automation of visual analyses typically performed manually with a conventional microscope. This method is further provided with a data processing function, wherein data stemming from multiple testing cycles may be collated, formatted, and presented for use by medical professionals in determining and projecting the effectiveness of a course of treatment.

    Vascular graft prosthesis
    6.
    发明授权
    Vascular graft prosthesis 失效
    血管移植假体

    公开(公告)号:US5849036A

    公开(公告)日:1998-12-15

    申请号:US623693

    申请日:1996-03-29

    CPC classification number: A61F2/06 A61M1/3653

    Abstract: A vascular graft prosthesis includes a tubular conduit for subcutaneous implantation. The tubular conduit has a first end for attachment to a vein, a second end for attachment to an artery, and an enlarged portion between the first and second ends. The enlarged portion has a diameter greater than the diameter of a remaining portion of said tubular conduit. The enlarged portion is positioned proximate the first end and spaced from the first end a distance substantially equivalent to a length of the enlarged portion.

    Abstract translation: 血管移植假体包括用于皮下植入的管状导管。 管状管道具有用于附接到静脉的第一端,用于附接到动脉的第二端和在第一和第二端之间的扩大部分。 扩大部分的直径大于所述管状导管的剩余部分的直径。 放大部分位于第一端附近并且与第一端部间隔开大致等于放大部分的长度的距离。

    System and Method for Facilitating Extracorporeal Inactivation of Pathogens of Blood Products

    公开(公告)号:US20220143287A1

    公开(公告)日:2022-05-12

    申请号:US17470371

    申请日:2021-09-09

    Abstract: A system and a method facilitate the extracorporeal inactivation of pathogens of blood products. The system includes an input peristaltic pump, at least one apheresis device, at least one plasma-treating system, and an output peristaltic pump. The input peristaltic pump, the apheresis device, the plasma-treating system, and the output peristaltic pump are in fluid communication with each other. The plasma-treating system includes at least one primary ultraviolet light (UVL) device, at least one heating device, and at least one cooling device. The input peristaltic pump facilitates the flow of blood from a patient through the system. The apheresis device facilitates separating of plasma from one or more blood cells. The plasma-treating system heats the plasma, inactivates pathogens within the plasma, and then cools the plasma. The output peristaltic pump facilitates the flow of blood from the system and back to the patient.

    METHODS OF IMPROVING FLUID DELIVERY
    8.
    发明申请
    METHODS OF IMPROVING FLUID DELIVERY 审中-公开
    改善流体输送的方法

    公开(公告)号:US20120059354A1

    公开(公告)日:2012-03-08

    申请号:US13078013

    申请日:2011-04-01

    Abstract: A method of reducing cell damage can include inserting device into a blood vessel, wherein the device includes a hollow shaft, a lumen, a fluid directing portion comprising a U-shaped lateral orifice extending between the exterior and interior surfaces and a corresponding U-shaped diverter adjacent to the U-shaped lateral orifice, wherein the diverter is disposed within the lumen and transverse to the central axis, and decreasing free plasma hemoglobin levels, thereby reducing damage to circulating blood cells or endothelium during dialysis.

    Abstract translation: 减少细胞损伤的方法可以包括将装置插入血管,其中装置包括中空轴,内腔,流体引导部分,其包括在外表面和内表面之间延伸的U形横向孔口和相应的U形 分流器邻近U形侧向孔口,其中分流器设置在腔内且横向于中心轴线,并且减少游离血浆血红蛋白水平,从而减少在透析期间对循环血细胞或内皮的损伤。

Patent Agency Ranking